ELAVL2 and gastric cancer: In gastric cancer (GC), we explored the role of Hub-ANSDR.Sig in immune dysfunction, tumor mutational burden (TMB), MSI, mutation frequency, immune infiltration, cell–cell communication, and developmental trajectories.